
This circular advises community pharmacy contractors on the amendments to the Drug Tariff Part 11 clawback scale.
Community Pharmacy Scotland’s 10th Annual Charity Golf Day was a swinging success, raising an incredible £8,732 for our 2025 charity partner, Held In Our Hearts.
Join our very own Graham Le Tissier as he shares his personal journey to quit smoking with the help of the updated Varenicline Service.
Our colleagues at LDUK have put together the following information to help raise awareness of Lyme Disease amongst community pharmacy health professionals.
New naloxone product added to emergency supply service. Updated service specification now available for community pharmacy teams.
Your next courier collection is scheduled for Thursday, June 5th, 2025. We have produced the following guidelines for your prescription bag submissions.
We would like to make you aware next month there will be several removed lines from Parts of the Scottish Drug Tariff – Part 2 Dressings, Part 3 Appliances & Part 4 Elastic Hosiery:
SSPs for Estradot® and Creon® extended. Pharmacists advised of new expiry dates: 6 June 2025 for Estradot®, 21 Nov 2025 for Creon® capsules.
This week’s MCR Ready Reckoner has been updated and is now available to download or you can view it via the App.
Due to the date on which the 1st of June falls the June Part 7 file will be published slightly later than the 1st with the possibility of this being early into next week.
The Scottish Government has issued updated guidance on the supply of puberty blockers for those under 18. Read now to ensure you’re up to date.
Nicola Jarvie seeks pharmacists for focus groups on digital prescribing as part of NHS Scotland’s community pharmacy engagement research.
Updated guidance for pharmacy provision of prophylactic paracetamol after MenB and other childhood vaccines, plus supporting clinical info.
In order to support our work with the Digital Prescribing and Dispensing Programme (DPDP), we would appreciate it if you are able to provide us some estimates for your pharmacy
The Chief Medical Officer has asked us to share the following advice with the network: Community pharmacists should not supply antiviral medicines in primary care on presentation of a GP10 prescription form.
We can now confirm that Pharmacy Technicians will be included under the updated definition of ‘regulated roles’ and will therefore require PVG Scheme membership from 1st April 2025.
Yesterday (14 May 2025), Community Pharmacy Scotland (CPS) welcomed members to the first Council session of the 2025 - 2028 term.
Your next courier collection is scheduled for Thursday, May 22nd, 2025. We have produced the following guidelines for your prescription bag submissions.
The First Minister of Scotland, John Swinney, announced this week the Programme for Government for 2025/26. He stated that "this programme is focused on delivery and hope. Delivery in response to the challenges we know people are facing in their everyday lives.
This Circular advises community pharmacy contractors that the four UK-wide Serious Shortage Protocols (SSPs) for Estradot® (estradiol) transdermal patches, a hormone replacement therapy (HRT) product, due to expire on 2 May 2025 have been extended.
The current Public Health Scotland poster campaign topic is Lyme Disease. The campaign aims to increase awareness of Lyme disease; how it is transmitted (via ticks) and vital signs and symptoms to look out for. Posters should be displayed within your pharmacy.
This article includes guidance around the process of submitting claims for the generic version of Varenicline. This applies to dispensing against prescriptions and the use of the newly re-launched PGD.
As a part of our work with the Scottish Government and Public Health Scotland, we regularly raise lines of concern and work to secure adjusted prices for these.
Your next courier collection is scheduled for Thursday, May 8th, 2025. We have produced the following guidelines for your prescription bag submissions.
The NHS circular PCA(P)(2025)08 informs NHS Boards and community pharmacy contractors of new arrangements in place for the procurement and reimbursement of Paxlovid® (nirmatrelvir and ritonavir).
Check out our Policy & PR Pharmacist, Sarah Scott, speaking to BBC Radio Scotland this morning about how people can manage insect bites and associated symptoms and how to access expert support through NHS Pharmacy First Scotland.
The Department of Health and Social Care (DHSC) has announced draft legislation has been laid out, with a view to the legislation coming into force for Hub and Spoke dispensing between different community pharmacy legal entities in October 2025 (The Human Medicines (Amendments Relating to Hub and Spoke Dispensing etc.) Regulations 2025).
The Community Pharmacy Scotland (CPS) Board has accepted the Scottish Government’s financial offer detailing the initial focus on the reimbursement arrangements within the community pharmacy funding envelope for the financial year 2025/26.
This circular sets out to community pharmacy contractors and Health Boards the details of the reimbursement arrangements as part of the community pharmacy funding settlement for 2025/26.
This circular advises community pharmacy contractors on the amendments to the Drug Tariff Part 11 clawback scale.
New naloxone product added to emergency supply service. Updated service specification now available for community pharmacy teams.
SSPs for Estradot® and Creon® extended. Pharmacists advised of new expiry dates: 6 June 2025 for Estradot®, 21 Nov 2025 for Creon® capsules.
Updated guidance for pharmacy provision of prophylactic paracetamol after MenB and other childhood vaccines, plus supporting clinical info.
This Circular advises community pharmacy contractors that the four UK-wide Serious Shortage Protocols (SSPs) for Estradot® (estradiol) transdermal patches, a hormone replacement therapy (HRT) product, due to expire on 2 May 2025 have been extended.
The NHS circular PCA(P)(2025)08 informs NHS Boards and community pharmacy contractors of new arrangements in place for the procurement and reimbursement of Paxlovid® (nirmatrelvir and ritonavir).
This circular sets out to community pharmacy contractors and Health Boards the details of the reimbursement arrangements as part of the community pharmacy funding settlement for 2025/26.
This Circular advises Health Boards and community pharmacy contractors of an updated Patient Group Direction (PGD) that is to be implemented for smoking cessation under the community pharmacy Public Health Service.
Please find attached NHS PCA(P)(2025)05 circular advising of a new Serious Shortage Protocol in place for Estradot® (Estradiol) 25 micrograms / 24 hours transdermal patch until Friday 2 May 2025.
Please find attached NHS circular PCA(P)(2025) 04 - Extension to Serious Shortage Protocols (SSPs) for Estradot (estradiol) 50, 75 and 100mcg patches, advising that the SSPs for the noted Estradot (estradiol) products have been extended until Friday 2 May 2025.
This Circular advises community pharmacy contractors that the Serious Shortage Protocol for Estradot® (Estradiol) 50 micrograms / 24 hours transdermal patch (SSP079), a hormone replacement therapy (HRT) product, due to expire on 21 March 2025 has been extended until Friday 4 April 2025.
This Circular advises community pharmacy contractors that the Serious Shortage Protocol for Estradot® (Estradiol) 50 micrograms / 24 hours transdermal patch, a hormone replacement therapy product has been extended.
This Circular advises community pharmacy contractors that the Serious Shortage Protocol (SSP) for cefalexin 125mg / 5ml oral suspension sugar free due to expire on 31 January 2025 has been extended until Friday 2 May 2025.
Serious Shortage Protocols (SSP) in place for cefalexin 125mg / 5ml & 250mg / 5ml oral suspension sugar free, from 10 December 2024 to 31 January 2025.
Serious Shortage Protocols (SSPs) are now in place for Estradot® (estradiol) 50 mcg, 75 mcg & 100 mcg / 24 hour transdermal patch, from 19 December 2024 to 28 January 2025.
This Circular informs NHS Boards and community pharmacy contractors of the intention to continue funding for Community Pharmacist Practitioner Champions in 2024-25.
This Circular advises community pharmacy contractors that the Serious Shortage Protocol (SSP) for Ramipril 2.5mg tablets due to expire on 15 November 2024 has been extended until Friday 29 November 2024.
This Circular advises community pharmacy contractors of a new Universal Claim Framework (UCF) module that will be available for use by providers of Pharmacy First Plus from 1 February 2025.
This Circular advises community pharmacy contractors that the Serious Shortage Protocol for isosorbide mononitrate (Monomax® XL) 60mg modified release tablet due to expire on 18 October 2024 has been extended until Friday 15 November 2024.
This Circular advises community pharmacy contractors of an updated Patient Group Direction (PGD) that is to be implemented for the provision of desogestrel as bridging contraception.
This Circular advises community pharmacy contractors of changes to NHS prescription stationery for the CP4/3 prescription form.
This circular sets out to community pharmacy contractors the details of the community pharmacy funding arrangement for 2024/25.
To advise of a Serious Shortage Protocol (SSP) in place for isosorbide mononitrate (Chemydur® 60XL) modified release tablet, from 6 September 2024 to 27 September 2024.
This Circular advises contractors of a balancing payment relating to the 2023/24 global sum, which will be made along with September’s payments.
To advise of a Serious Shortage Protocol (SSP) in place for cefalexin 500mg tablets, from 6 August 2024 to 27 September 2024.
To advise of a Serious Shortage Protocol (SSP) in place for ramipril 2.5mg tablets, from 6 August 2024 to 15 November 2024.
The Scottish Government have released Circulars PCA(2024)12 through to 20 advising of Serious Shortage Protocols (SSPs) that are in place in relation to supply issues with Quetiapine 150mg, 200mg and 300mg tablets.
This Circular advises community pharmacy contractors that the two UK-wide Serious Shortage Protocols (SSPs) for Clarithromycin antibiotic products due to expire on 21 June 2024 have now been extended until Friday 19 July 2024.
This Circular advises Health Boards and community pharmacy contractors that a series of Public Health Service (PHS) poster campaigns is planned to be distributed to pharmacies over the course of 2024/25
This Circular advises Health Boards and community pharmacy contractors that the two UK-wide Serious Shortage Protocols (SSPs) for Clarithromycin 125mg/5ml and 250mg/5ml oral suspension have been reactivated on 22 May 2024. The new end date for both SSPs is now 21 June 2024.

Read Victoria’s incredible real-world story of how a routine consultation through the NHS Pharmacy First Plus service led to the urgent referral of a patient who was later diagnosed with leukaemia.
Check out our Policy & PR Pharmacist, Sarah Scott, speaking to BBC Radio Scotland this morning about how people can manage their hay fever symptoms and access expert support through NHS Pharmacy First Scotland.
The Scottish Government has published its NHS Operational Improvement Plan, which describes how the commitments outlined in the First Minister’s January speech will be delivered. In his speech, First Minister John Swinney announced plans to make it easier for people to see a first point of contact with the NHS, for example a community pharmacist. The Operational Improvement Plan states that the Scottish Government will further expand the NHS Pharmacy First Scotland service, enabling community pharmacists to treat a greater number of clinical conditions.
The approved list of products for the NHS Pharmacy First Scotland Service has been updated from the 1st March 2025.
Do you have questions about NHS Pharmacy First Scotland / NHS PFS Plus and or the UCF Module?
First Minister John Swinney addressed the nation yesterday (27/01/25) to outline plans for NHS reform, pledging to reduce waiting lists, enhance the NHS Pharmacy First Scotland service.
Our Policy and PR Pharmacist attended the Norsk Farmasoytisk Selskap Pharmacy Conference in Oslo last Thursday where she gave a presentation on NHS Pharmacy First Scotland.
There has been an update to the NHS Pharmacy First Scotland Approved List.
Community Pharmacy Scotland has been made aware of confusion around some of the NHS Pharmacy First Scotland service (PFS) Urinary Tract Infection (UTI) Patient Group Direction (PGD) details. We thought it would be useful to clarify these points.
Our colleagues at Scottish Government have produced an NHS Pharmacy First Scotland Service Communications Toolkit to help promote Pharmacy First services in Scotland. There are two kits available: one specifically for women's health services and one for general services.
There has been an update to the respiratory section of the NHS Pharmacy First (Scotland) Service Approved List of Products. This means that there are no longer any products listed under cough. It was agreed to remove Simple linctus sugar free, all pack sizes.
There has been an update to the NHS Pharmacy First Scotland Approved List.
guidance for the NHS Pharmacy First Scotland (NHS PFS) service, which is in response to previous questions and outcomes from live events held with the community pharmacy network.
Referrals into community pharmacy from other healthcare professionals are becoming more frequent as community pharmacy services become more well known. This may result in an increase in recommendations to patients from other healthcare professionals when referring them to the community pharmacy for care.
The Scottish Government have updated the NHS Pharmacy First Approved List and to follow national prescribing guidance Simple Linctus sugar-free and Simple Linctus Paediatric sugar-free have now been removed from this list.
The update is to Section 10 Skin to remove Epimax Ointment and Epimax Paraffin free Ointment from NHS Grampian’s list only.
The NHS Pharmacy First Scotland Service approved list of products has been updated as of 1st of April 2024.
This Circular advises Health Boards and community pharmacy contractors of updated Patient Group Directions (PGDs) that are to be implemented for the treatment of shingles and skin infections under NHS Pharmacy First Scotland.
We have been working with Scottish Government and NHS colleagues on trying to capture Pharmacy First Plus prescribing, advice and referrals data to better evidence the great work being done out in the network – at the moment, this cannot be separated out from standard Pharmacy First activity.
As some of you may be aware, NHS England are due to launch the NHS Pharmacy First service in English community pharmacies on 31st of January 2024.
Each local NHS Health Board has the ability to develop bespoke local pharmacy services to suit the needs of local communities and patients
This Circular provides updated guidance aimed at both community optometry and community pharmacy teams and an updated referral form for the assessment and treatment of minor eye conditions.
Patient Group Directions (PGDs) that are to be added to the NHS Pharmacy First Scotland service for the treatment of seasonal allergic rhinitis (hay fever).
This Circular advises Health Boards and community pharmacy contractors of updated Patient Group Directions (PGDs) that are to be implemented for the treatment of urinary tract infections (UTI) and impetigo under NHS Pharmacy First Scotland.
As part of a move to a regional formulary review process in the East of Scotland, both NHS Lothian and NHS Borders will very shortly inform contractors that the dose of Flucloxacillin permitted
Our colleagues in Primary Care have highlighted the attached website as a source of information for professionals and patients which you may find useful in your practice, and Pharmacy First and First Plus in particular.
Circular PCA(P)(2021)5 set out the arrangements for the settlement for pharmaceutical services for the period 2020-21, including for NHS Pharmacy First Scotland.
Since its launch in the midst of the pandemic, you and your teams have supported the people of Scotland with their minor health conditions over 2 million times!
With the Revised List of Approved List Products (PCA (P) (2021) 14) Circular, from 1st October 2021
This Circular encloses a revised Approved List of Products for the NHS Pharmacy First Scotland service, which will come into force from 1st October 2021.
The approved list of products for the NHS Pharmacy First Scotland Service has been updated from the 1st March 2025.